Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EFG Asset Management
London, United Kingdom
- Ownership
- Private
- Employees
- ~450
- Development stage
- Other
01
Overview
EFG Asset Management (EFGAM) is an international investment management firm and the asset management arm of EFG International. While not a biotechnology company itself, EFGAM is a significant participant in the life sciences sector through its specialized investment strategies, such as the New Capital Healthcare Disruptors Fund. The firm focuses on identifying and investing in companies at the forefront of medical innovation, including genomics, immunotherapy, and digital health. EFGAM provides active management and research-driven investment solutions to institutional and private clients globally from its hubs in London, Zurich, and Hong Kong.
- Industry
- Investors
Beyond the preview
Go deeper on EFG Asset Management.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on EFG Asset Management.